ArticleBMC research notes2019

Pharmacological profiling of a dual FAK/IGF-1R kinase inhibitor TAE226 in cellular and in vivo tumor models.

Shigemi Fukami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.